November 18th, 2013
Selections from Richard Lehman’s Literature Review: November 18th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include the VA-NEPHRON-D and IABP-SHOCK II trials, a study of the sex differences in ACS symptoms among young patients, and more.
August 30th, 2011
No Benefit for Routine Counterpulsation Found in CRISP AMI
Larry Husten, PHD
Routine use of intra-aortic balloon counterpulsation (IABC) in STEMI patients who do not have cardiogenic shock does not reduce infarct size, according to a new trial. Results from the CRISP AMI (Counterpulsation to Reduce Infarct Size Pre-PCI Acute Myocardial Infarction) trial were presented at the European Society of Cardiology meeting in Paris by Manesh Patel […]
NEJM Journal Watch — Recent Cardiology Articles- Self-Expanding Supraannular Valve vs. Balloon-Expandable Valve in TAVR for Small Aortic Annulus
- A New TAVR Prosthesis for Aortic Regurgitation Shows Promise
- Aprocitentan, a Newly Approved Drug for Resistant Hypertension
- Preventive PCI of Vulnerable Plaques Linked to Fewer Cardiac Events
- News from the ACC Scientific Session 2024